Skip to content
Screener

Biogen BIIB Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$53.01M-34.3%
Regenxbio logo
RegenxbioRGNX
$22.7M+132%
Scholar Rock logo
Scholar RockSRRK
-$109.45M+0.6%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.72B+63.7%
Enterprise value$36.99B+63.7%
P/E34.8×+22.5×
P/S3.1×+1.2×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The source filing: Biogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:36 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000875045-26-000075
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Net income attributable to Biogen Inc.$97.5$634.8$417.0$875.3
Other comprehensive income (loss):
Unrealized gains (losses) on securities available for sale, net of tax1.6(0.2)
Unrealized gains (losses) on cash flow hedges, net of tax14.8(105.8)67.4(163.6)
Unrealized gains (losses) on pension benefit obligation, net of tax(0.3)0.6(0.8)1.0
Currency translation adjustments, net of tax(3.6)41.6(12.1)60.7
Total other comprehensive income (loss), net of tax12.5(63.6)54.3(101.9)
Comprehensive income (loss) attributable to Biogen Inc.$110.0$571.2$471.3$773.4

Item 1. Financial Statements (unaudited)

FAQ

What is Biogen's comprehensive income (loss), net of tax, attributable to parent?
Biogen (BIIB) reported comprehensive income (loss), net of tax, attributable to parent of $110M in Q2 2026.
How has Biogen's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Biogen's comprehensive income (loss), net of tax, attributable to parent decreased by 80.7% year-over-year, from $571.2M to $110M.

Ask your AI about Biogen's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude